首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1347197

2030 年地中海鱼类疫苗市场预测 - 按疫苗类型、给药途径、物种和国家进行区域分析

Mediterranean Fish Vaccine Market Forecast to 2030 - Regional Analysis by Vaccine Type, Route of Administration, Species, and Country

出版日期: 2023年08月10日 | 出版商:

The Insight Partners | 英文 199 Pages | 订单完成后即时交付

价格

简介目录图表

地中海鱼苗市场规模预计将从2022年的963.2346亿美元增至2030年的2090.308亿美元；预计2022年至2030年復合年增长率为10.2%。

消费者越来越意识到动物蛋白的营养价值。对更少或不含药物的健康、可持续、高质量肉製品的需求也在迅速增长。对水生动物食品（油、鱼子酱、蛋白粉、肉类等）的需求不断增长，鼓励农民接种疫苗以保障水产养殖并获得高利润。

作为健康饮食的一部分，经常食用鱼类被广泛提倡。与陆生动物肉相比，鱼类的蛋白质含量较高，这一点通过饲料转化率 (FCR) 低于陆生动物即可看出。此外，鱼蛋白易消化且富含必需氨基酸，这与必需氨基酸含量较低的动物源蛋白不同。通过不同的研究，食用鱼类和贝类与降低心脏病、炎症和关节炎的风险有关。鱼的健康益处主要与长链 omega 3 (n-3) 多不饱和脂肪酸 (PUFA) 的存在有关。此外，鱼蛋白富含生物活性肽，如果以适当的浓度食用以支持其在人体内的最佳生物利用度，则可以提供许多健康益处。食用鱼类的其他健康益处包括通过抑制肾素-血管紧张素-醛固酮系统（RAAS）内的酶来控制血压；维持骨骼健康；控制炎症（抗氧化肽）；通过阿片肽和血小板激活因子乙酰水解酶（PAF-AH）抑制肽的作用维持心理健康；等等。因此，水生动物源性蛋白质对健康的巨大益处表明需要对这些动物进行健康饲养，从而推动了地中海地区对鱼类疫苗的需求。

新型疫苗的开发：地中海鱼疫苗市场的机会

由细菌、病毒和寄生虫引起的各种疾病的爆发已经减缓了全球水产养殖业的发展数十年。除了危害人类健康外，新出现的疾病也极大地影响水生动物。疫苗接种是一种众所周知的、有效的预防措施，用于解决这个问题。然而，传统疫苗仍然存在一些缺点和局限性，这促使研究人员将注意力转向嵌合多表位疫苗等新型疫苗。基于目前对基因组学和免疫蛋白质组学的理解以及目前可用的生物信息学工具，研究人员现在可以识别免疫细胞识别的潜在目标表位。此外，随着全基因组测序等技术的成本持续下降，它为物种特异性疫苗的开发开闢了道路。这些因素可能会鼓励地中海鱼类疫苗市场参与者投资开发针对目前尚无疫苗的病毒、寄生虫或细菌传染病的新疫苗。

此外，有效粘膜疫苗的开发及其管理流程的优化预计将加速新型疫苗的开发，进而鼓励地中海国家的水产养殖企业规范鱼类疫苗接种流程。紧急（自体）疫苗的有效使用预计将有助于应对新出现的疾病挑战，并为市场参与者创造巨大的发展机会。

地中海鱼类疫苗市场分为疫苗类型、物种、给药途径、临床适应症和国家。根据疫苗类型，市场分为灭活疫苗、减毒活疫苗、类毒素疫苗、亚单位疫苗、结合疫苗和重组载体疫苗。根据物种，地中海鱼类疫苗市场分为大菱鲆、欧洲鳀鱼和鲈鱼、鲑鱼、地中海鲈鱼、普通齿鱼和普通潘多拉鱼、鲷鱼、虹鳟、黑鲷、鳟鱼、地中海箭鱼和蓝鳍金枪鱼、石斑鱼和琥珀鱼等。从给药途径来看，市场分为浸没疫苗、注射疫苗和口服疫苗。并根据临床适应症，市场分为细菌感染和病毒感染。根据地区，对法国、意大利、西班牙、埃及、希腊、土耳其、以色列和地中海其他地区的市场进行了分析。该地区市场的增长是由蓬勃发展的水产养殖业和加强疫苗研发的倡议推动的。土耳其在世界上最大的海水鱼类养殖国中排名第九，其水产养殖产量在所有欧洲国家中名列前茅。水产养殖占土耳其海鲜年产量的 44.6% 左右。该国声称拥有世界上增长最快的食品生产工业。土耳其拥有 434 个正在运营的海水养殖设施，生产金头鲷和欧洲鲈鱼。过去二十年，技术进步促进了鲈鱼和鲷鱼产量的快速增长。因此，该国已成为世界上最大的鲷鱼和鲈鱼生产国，满足全球约 40% 的需求。此外，由于政府努力将鱼类推广为低碳足蹟的健康产品，该国的鱼类消费量正在上升。根据土耳其海洋研究基金会 (TUDAV) 2021 年 1 月发布的估计，到 2023 年，该国的鱼类产量将达到 60 万吨，出口额为 170 万美元（160 万欧元）。

另一方面，管理水产养殖和养鱼场的各种疾病是土耳其水产养殖企业面临的主要挑战。这一挑战可以通过定期鱼类疫苗接种来应对。因此，土耳其大规模的鱼类生产可能会扩大未来几年对鱼类疫苗的需求。

联合国粮食及农业组织 (FAO)、经济合作与发展组织 (OECD)、欧盟、土耳其海洋研究基金会 (TUDAV) 是编写报告时提到的几个关键的主要和次要来源地中海鱼类疫苗市场。

Consumers are becoming aware of the nutritious value of animal protein. The demand for healthy, sustainable, high-quality meat products with fewer or no drugs is also increasing rapidly. The growing demand for food products derived from aquatic animals (oil, caviar, protein powders, meat, etc.) encourages farmers to undertake vaccinations to safeguard aquaculture and attain high profitability.

Regular fish consumption is widely promoted as a part of a healthy diet. Fishes have a high protein content compared to terrestrial animal meat, which is evident through lower feed conversion rates (FCR) than land animals. Moreover, fish proteins are highly digestible and rich in essential amino acids, unlike animal-sourced proteins that have low essential amino acid content. Fish and shellfish consumption has been associated with a decreased risk of heart disease, inflammation, and arthritis through different research studies. The health benefits of fish are mainly linked to the presence of long-chain omega 3 (n-3) polyunsaturated fatty acids (PUFA). In addition, fish proteins are enriched with bioactive peptides, which offer many health benefits if consumed in appropriate concentrations that support their optimal bioavailability within the human body. Other health benefits of fish consumption include the control of blood pressure through the inhibition of enzymes within the renin-angiotensin-aldosterone system (RAAS); maintenance of bone health; control of inflammation (antioxidant peptides); and maintenance of mental health through the action of opioid peptides and platelet-activating factor acetyl-hydrolase (PAF-AH) inhibitory peptides; and so on. Thus, the tremendous health benefits of aquatic animal-derived proteins indicate the need for healthy breeding of these animals, which propels the demand for fish vaccines in the Mediterranean region.

Development of Novel Vaccines: Opportunity for the Mediterranean Fish Vaccine Market

Various disease outbreaks caused by bacteria, viruses, and parasites have decelerated the progress of the global aquaculture industry for several decades. Besides harming human health, emerging diseases also dramatically affect aquatic animals. Vaccination is a well-known, effective prophylactic measure employed to manage this problem. However, traditional vaccines still have several drawbacks and limitations, which has driven the focus of researchers to novel vaccines such as chimeric multiepitope vaccines. Based on the current understanding of genomics and immunoproteomics, and the presently available bioinformatics tools, researchers can now identify the potential targeted epitopes that are recognized by immune cells. Further, Fish Species with a as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. These factors are likely to encourage the Mediterranean fish vaccine market players to invest in developing new vaccines against viral, parasitic, or bacterial infectious diseases for which vaccines are presently unavailable.

Further, the development of effective mucosal vaccines and optimization of their administration process are expected to accelerate novel vaccine development, in turn, encouraging aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. The effective use of emergency (autogenous) vaccines is anticipated to help handle emerging disease challenges and create immense opportunities for the market players to grow.

The Mediterranean fish vaccine market is segments into vaccine type, species, route of administration, clinical indication, and country. Based on the vaccine type, the market is bifurcated into inactivated vaccine, live-attenuated vaccine, toxoid vaccine, subunit vaccine, conjugate vaccine, and recombinant vector vaccine. Based on species, the Mediterranean fish vaccine market is bifurcated into turbot, European anchovy and seabass, salmon, Mediterranean sea bass, common dentex and common pandora, sea bream, rainbow wrasse, Sparus aurata, trout, Mediterranean swordfish and bluefin tuna, grouper and amberjack, and others. In terms of route of administration, the market is segmented into immersion vaccine, injection vaccine, and oral vaccine. And based on clinical indication, the market is classified as bacterial infection and viral infection. Based on the region, the market is analyzed on the basis of France, Italy, Spain, Egypt, Greece, Turkey, Israel, and the Rest of the Mediterranean. The growth of the market in this region is driven by the flourishing aquaculture industry and increasing initiatives to enhance research and development of vaccines. Turkey ranks ninth among the largest marine fish farming countries in the world, and it records significant aquaculture production among all European countries. Aquaculture accounts for ~44.6% of the total annual seafood production in Turkey. The country claims to have the fastest-growing food production industry in the world. Turkey has 434 operational marine aquaculture facilities, producing gilthead seabream and European seabass. Technological advancements have facilitated the rapid growth in sea bass and sea bream production in the past two decades. Thus, the country has become the world's top producer of sea bream and sea bass, meeting ~40% of the global demand. Moreover, fish consumption in the country is rising due to the government's efforts to promote fish as a healthy product with a low carbon footprint. According to the Turkish Marine Research Foundation (TUDAV) estimates published in January 2021, the country's fish production would reach 600,000 tons by 2023, accounting for exports of US$ 1.7 million (€1.6 million).

On the other hand, managing various diseases in aquaculture and fish farms is a major challenge faced by Turkish aquaculture businesses. This challenge is handled by regular fish vaccination. Thus, the large scale of fish production in Turkey is likely to expand the demand for fish vaccines in the coming years.

The Food and Agriculture Organization of the United Nations (FAO), the Organisation for Economic Co-operation and Development (OECD), European Union, Turkish Marine Research Foundation (TUDAV) are a few key primary and secondary sources referred to while preparing the report on the Mediterranean fish vaccine market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Mediterranean fish vaccine market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global Mediterranean fish vaccine market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global Mediterranean fish vaccine market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Mediterranean Fish Vaccine Market - Market Landscape

4.1 Overview
- 4.1.1 Mediterranean Region PEST Analysis
4.2 Mediterranean Fish Species
4.3 List of Mediterranean Fish Species

5. Mediterranean Fish Vaccine Market - Regional Analysis

5.1 Key Market Drivers:
- 5.1.1 Government Initiatives to Develop Mediterranean Aquaculture Industry
- 5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
5.2 Key Market Restraints:
- 5.2.1 Strict Regulatory Policies for Approval of Vaccines
5.3 Key Market Opportunities:
- 5.3.1 Development of Novel Vaccines
5.4 Future Trends:
- 5.4.1 Shift from Conventional Vaccines to DNA Vaccines
5.5 Impact Analysis:

6. Mediterranean Fish Vaccine Market - Regional Analysis

6.1 Mediterranean Fish Vaccine Market Revenue Forecast and Analysis

7. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

7.1 Overview
7.2 Mediterranean Fish Vaccine Market Revenue Share, by Vaccine Type 2022 & 2030 (%)
7.3 Inactivated Vaccine
- 7.3.1 Overview
- 7.3.2 Inactivated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Live Attenuated Vaccine
- 7.4.1 Overview
- 7.4.2 Live Attenuated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Toxoid Vaccine
- 7.5.1 Overview
- 7.5.2 Toxoid Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Subunit Vaccine
- 7.6.1 Overview
- 7.6.2 Subunit Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Conjugate Vaccine
- 7.7.1 Overview
- 7.7.2 Conjugate Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Recombinant Vector Vaccine
- 7.8.1 Overview
- 7.8.2 Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

8. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

8.1 Overview
8.2 Mediterranean Fish Vaccine Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.3 Immersion Vaccine
- 8.3.1 Overview
- 8.3.2 Immersion Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Injection Vaccine
- 8.4.1 Overview
- 8.4.2 Injection Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Oral Vaccine
- 8.5.1 Overview
- 8.5.2 Oral Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

9. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Species.

9.1 Overview
9.2 Mediterranean Fish Vaccine Market Revenue Share, by Species 2022 & 2030 (%)
9.3 Turbot
- 9.3.1 Turbot: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.4 European Anchovy and Seabass
- 9.4.1 European Anchovy and Seabass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Salmon
- 9.5.1 Salmon: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Mediterranean Sea Bass
- 9.6.1 Mediterranean Sea Bass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Common Dentex and Common Pandora
- 9.7.1 Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Sea Bream
- 9.8.1 Sea Bream: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Rainbow Wrasse
- 9.9.1 Rainbow Wrasse: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.10 Sparus aurata
- 9.10.1 Sparus aurata: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.11 Trout
- 9.11.1 Trout: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.12 Mediterranean Swordfish and Bluefin Tuna
- 9.12.1 Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.13 Grouper and Amberjack
- 9.13.1 Grouper and Amberjack: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
9.14 Others
- 9.14.1 Others: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

10. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - by Clinical Indication

10.1 Overview
10.2 Mediterranean Fish Vaccine Market Revenue Share, by Clinical Indication 2022 & 2030 (%)
10.3 Bacterial Infection
- 10.3.1 Overview
- 10.3.2 Bacterial Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Viral Infection
- 10.4.1 Overview
- 10.4.2 Viral Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)

11. Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 - Geographic Analysis

11.1 Mediterranean Fish Vaccine Market, Revenue and Forecast to 2030
- 11.1.1 Overview
- 11.1.2 Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
  - 11.1.2.1 Mediterranean Fish Vaccine Market, by Vaccine Type
  - 11.1.2.2 Mediterranean Fish Vaccine Market, by Route of Administration
  - 11.1.2.3 Mediterranean Fish Vaccine Market, by Species
  - 11.1.2.4 Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.4.1 Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.4.2 Mediterranean Fish Vaccine Market, by Bacterial Infection
  - 11.1.2.5 Mediterranean Fish Vaccine Market by Country
    - 11.1.2.5.1 France
    - 11.1.2.5.1.1 Overview
    - 11.1.2.5.1.2 France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.1.2.1 France: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.1.2.2 France: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.1.2.3 France: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.1.2.4 France: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.1.2.4.1 France: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.1.2.4.2 France: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.2 Italy
    - 11.1.2.5.2.1 Overview
    - 11.1.2.5.2.2 Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.2.2.1 Italy: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.2.2.2 Italy: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.2.2.3 Italy: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.2.2.4 Italy: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.2.2.4.1 Italy: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.2.2.4.2 Italy: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.3 Spain
    - 11.1.2.5.3.1 Overview
    - 11.1.2.5.3.2 Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.3.2.1 Spain: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.3.2.2 Spain: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.3.2.3 Spain: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.3.2.4 Spain: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.3.2.4.1 Spain: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.3.2.4.2 Spain: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.4 Egypt
    - 11.1.2.5.4.1 Overview
    - 11.1.2.5.4.2 Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.4.2.1 Egypt: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.4.2.2 Egypt: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.4.2.3 Egypt: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.4.2.4 Egypt: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.4.2.4.1 Egypt: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.4.2.4.2 Egypt: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.5 Israel
    - 11.1.2.5.5.1 Overview
    - 11.1.2.5.5.2 Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.5.2.1 Israel: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.5.2.2 Israel: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.5.2.3 Israel: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.5.2.4 Israel: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.5.2.4.1 Israel: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.5.2.4.2 Israel: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.6 Turkey
    - 11.1.2.5.6.1 Overview
    - 11.1.2.5.6.2 Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.6.2.1 Turkey: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.6.2.2 Turkey: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.6.2.3 Turkey: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.6.2.4 Turkey: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.6.2.4.1 Turkey: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.6.2.4.2 Turkey: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.7 Greece
    - 11.1.2.5.7.1 Overview
    - 11.1.2.5.7.2 Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.7.2.1 Greece: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.7.2.2 Greece: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.7.2.3 Greece: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.7.2.4 Greece: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.7.2.4.1 Greece: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.7.2.4.2 Greece: Mediterranean Fish Vaccine Market, by Viral Infection
    - 11.1.2.5.8 Rest of the Mediterranean
    - 11.1.2.5.8.1 Overview
    - 11.1.2.5.8.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.8.2.1 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Vaccine Type
    - 11.1.2.5.8.2.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Route of Administration
    - 11.1.2.5.8.2.3 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Species
    - 11.1.2.5.8.2.4 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Clinical Indication
    - 11.1.2.5.8.2.4.1 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Bacterial Infection
    - 11.1.2.5.8.2.4.2 Rest of the Mediterranean: Mediterranean Fish Vaccine Market, by Viral Infection

12. Pre and Post COVID-19 Impact

12.1 Pre and Post COVID-19 Impact

13. Mediterranean Fist Vaccine Market - Industry Landscape

13.1 Overview
13.2 Growth Strategies in Mediterranean Fish Vaccine Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Zoetis Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Merck & Co Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 HIPRA SA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 ICTYODEV SAS
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 ACUIPHARMA AQUACULTURE HEALTH SL
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Phibro Animal Health Corp
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Vaxxinova International BV
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Kyoto Biken Laboratories Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Elanco Animal Health Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Ceva SA
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Mediterranean Fish Vaccine Market Segmentation
Table 2. Species of Fishes, Disease and Available Vaccine -
Table 3. Bacterial Pathogens of Fishes -
Table 4. USDA Approved Bacterial Fish Vaccines -
Table 5. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 6. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 7. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Species
Table 8. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Clinical Indication
Table 9. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Bacterial Infection
Table 10. Mediterranean Fish Vaccine Market Revenue and Forecast To 2030 (US$ Mn) - Viral Infection
Table 11. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 12. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 13. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 14. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 15. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 16. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 17. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 18. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 19. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 20. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 21. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 22. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 23. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 24. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 25. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 26. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 27. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 28. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 29. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 30. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 31. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 32. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 33. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 34. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 35. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 36. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 37. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 38. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 39. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 40. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 41. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 42. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 43. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 44. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 45. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 46. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 47. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 48. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 49. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Species
Table 50. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Clinical Indication
Table 51. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 52. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 53. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Vaccine Type
Table 54. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 55. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) -Species
Table 56. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) -Clinical Indication
Table 57. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Bacterial Infection
Table 58. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn) - Viral Infection
Table 59. Recent Inorganic Growth Strategies in the Mediterranean Fish Vaccine Market
Table 60. Recent Organic Growth Strategies in Mediterranean fish vaccine Market
Table 61. Glossary of Terms

List Of Figures

Figure 1. Mediterranean Fish Vaccine Market Segmentation, By Region
Figure 2. Mediterranean Region: PEST Analysis
Figure 3. Mediterranean Fish Vaccine Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Mediterranean Fish Vaccine Market - Revenue Forecast and Analysis - 2020-2030
Figure 6. Mediterranean Fish Vaccine Market Revenue Share, by Vaccine Type 2022 & 2030 (%)
Figure 7. Inactivated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Live Attenuated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Toxoid Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Subunit Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Conjugate Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Mediterranean Fish Vaccine Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 14. Inactivated Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Injection Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Toxoid Vaccine: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Mediterranean Fish Vaccine Market Revenue Share, by Species 2022 & 2030 (%)
Figure 18. Turbot: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. European Anchovy and Seabass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Salmon: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mediterranean Sea Bass: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Sea Bream: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rainbow Wrasse: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Sparus aurata: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Trout: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Grouper and Amberjack: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Others: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Mediterranean Fish Vaccine Market Revenue Share, by Clinical Indication 2022 & 2030 (%)
Figure 31. Bacterial Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Viral Infection: Mediterranean Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Mediterranean Fish Vaccine Market, By Region, 2022 ($Mn)
Figure 34. Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Mediterranean Fish Vaccine Market, By Key Countries, 2022 And 2030 (%)
Figure 36. France: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Italy: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Spain: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Egypt: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Israel: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Turkey: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Greece: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Rest of the Mediterranean: Mediterranean Fish Vaccine Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. Pre and Post COVID-19 Impact on Mediterranean Fish Vaccine Market
Figure 45. Growth Strategies in Mediterranean Fish Vaccine Market

02-2729-4219

+886-2-2729-4219

License/价格

2030 年地中海鱼类疫苗市场预测 - 按疫苗类型、给药途径、物种和国家进行区域分析

Mediterranean Fish Vaccine Market Forecast to 2030 - Regional Analysis by Vaccine Type, Route of Administration, Species, and Country

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

第 4 章：地中海鱼疫苗市场 - 市场格局

第 5 章：地中海鱼疫苗市场 - 区域分析

第 6 章：地中海鱼疫苗市场 - 区域分析

第 7 章：地中海鱼疫苗市场 - 收入和 2030 年预测 - 按疫苗类型

第 8 章：地中海鱼疫苗市场 - 收入和 2030 年预测 - 按给药途径

第 9 章：地中海鱼疫苗市场 - 收入和 2030 年预测 - 按物种。

第 10 章：地中海鱼疫苗市场 - 收入和 2030 年预测 - 按临床适应症

第 11 章：地中海鱼疫苗市场 - 收入和 2030 年预测 - 地理分析

第 12 章：COVID-19 前后的影响

第 13 章：地中海拳头疫苗市场 - 行业格局

第 14 章：公司简介

第 15 章：附录